Background illustration for clinical trials search

Paid Clinical Trials Meridian

Discover 224 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy

for
TBI Traumatic Brain Injury,
Location: Boise ID
Sponsor: Summit Hyperbarics and Wellness

Sex: All

Age: 18 - 70+

Code: NCT07214415

Phase 2, Recruiting
Active & Responsive

HBOT Effects on First Responders' Cognition and Well-Being

for
Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder,
Location: Boise ID
Sponsor: Summit Hyperbarics and Wellness

Sex: All

Age: 18 - 70+

Code: NCT07852728

Phase 2, Recruiting
Active & Responsive

Hyperbaric Oxygen Therapy for Veterans With TBI and PCS: A Biomarker Study

for
Traumatic Brain Injury (TBI) Patients, Post Concussive Symptoms,
Location: Boise ID
Sponsor: Summit Hyperbarics and Wellness

Sex: All

Age: 18 - 70+

Code: NCT07849465

Phase 2, Recruiting
Active & Responsive

Long-Term Outcomes Following HBOT

for
Traumatic Brain Injury, Post-Concussive Symptoms,
Location: Boise ID
Sponsor: Summit Hyperbarics and Wellness

Sex: All

Age: 18+

Code: NCT07732374

Phase 2, Recruiting

A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age

for
Influenza, Human
Location: Meridian ID, Glendale AZ, San Diego CA, Tucson AZ,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 64

Code: NCT07851246

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Meridian ID, Boise ID, Nampa ID, Caldwell ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase 3, Recruiting

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Meridian ID, Boise ID, Nampa ID, Caldwell ID,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06580314

Phase 3, Recruiting

Specimen Collection From Patients With Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

for
Non-hematologic Cancer
Location: Boise ID
Sponsor: Sequenom, Inc.

Sex: All

Age: 18+

Code: NCT02586389

Recruiting

Family Communications After Genetic Testing

for
Colon Adenocarcinoma, Colorectal Adenocarcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07143487

Recruiting

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

for
Prostate Cancer Detection
Location: Meridian ID, San Diego CA, Bowling Green KY, Towson MD,
Sponsor: Sequenom, Inc.

Sex: Male

Age: 40 - 70+

Code: NCT07543757

Recruiting

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

for
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04840602

Phase 2, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase 3, Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for
Pancreatic Neoplasm
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

for
Urinary Incontinence, Urinary Incontinence,Stress
Location: Meridian ID, Denver CO, Omaha NE, Hershey PA
Sponsor: Uromedica

Sex: Female

Age: 22+

Code: NCT04248283

Recruiting

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

for
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID, Emmett ID,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT05806515

Phase 2, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase 2, Phase 3, Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

for
Acral Lentiginous Melanoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID, Emmett ID,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04511013

Phase 2, Recruiting

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

for
Advanced Lung Non-Small Cell Carcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03191149

Phase 2, Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

for
Intracranial Meningioma, Recurrent Meningioma,
Location: Meridian ID, Boise ID, Caldwell ID, Ontario OR,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT02523014

Phase 2, Recruiting

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

for
Castration-Resistant Prostate Carcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT06470243

Phase 3, Recruiting